Ryman Healthcare Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 1.4yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Is Ryman Healthcare (NZSE:RYM) Weighed On By Its Debt Load?
Aug 16
Are Investors Undervaluing Ryman Healthcare Limited (NZSE:RYM) By 47%?
Jul 12Ryman Healthcare's (NZSE:RYM) Soft Earnings Don't Show The Whole Picture
Jun 05Little Excitement Around Ryman Healthcare Limited's (NZSE:RYM) Earnings
May 21Returns On Capital At Ryman Healthcare (NZSE:RYM) Paint A Concerning Picture
Apr 24Ryman Healthcare Limited's (NZSE:RYM) P/E Is On The Mark
Feb 08Here's Why Ryman Healthcare (NZSE:RYM) Has A Meaningful Debt Burden
Jan 07Capital Allocation Trends At Ryman Healthcare (NZSE:RYM) Aren't Ideal
Dec 20What Is Ryman Healthcare Limited's (NZSE:RYM) Share Price Doing?
Sep 11Ryman Healthcare (NZSE:RYM) Has Debt But No Earnings; Should You Worry?
Jul 04Ryman Healthcare Limited (NZSE:RYM) Shares Could Be 24% Below Their Intrinsic Value Estimate
May 30Should You Think About Buying Ryman Healthcare Limited (NZSE:RYM) Now?
Aug 26When Should You Buy Ryman Healthcare Limited (NZSE:RYM)?
May 04What Is Ryman Healthcare Limited's (NZSE:RYM) Share Price Doing?
Jan 08Investors Could Be Concerned With Ryman Healthcare's (NZSE:RYM) Returns On Capital
Oct 14Is It Too Late To Consider Buying Ryman Healthcare Limited (NZSE:RYM)?
Sep 14Is Ryman Healthcare (NZSE:RYM) Using Too Much Debt?
Aug 04Should You Think About Buying Ryman Healthcare Limited (NZSE:RYM) Now?
May 22Is Ryman Healthcare Limited (NZSE:RYM) A Good Fit For Your Dividend Portfolio?
Apr 17Should You Review Recent Insider Transactions At Ryman Healthcare Limited (NZSE:RYM)?
Mar 20Our Take On The Returns On Capital At Ryman Healthcare (NZSE:RYM)
Mar 07Do Institutions Own Ryman Healthcare Limited (NZSE:RYM) Shares?
Feb 23Returns On Capital At Ryman Healthcare (NZSE:RYM) Paint An Interesting Picture
Nov 23CEO
Ryman Healthcare has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.4yrs | NZ$221.67k | 0.0012% NZ$ 42.1k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Transformation & Strategy Officer and COO | less than a year | no data | no data | |
| Chief Customer & Technology Officer | 4.1yrs | no data | no data | |
| Chief People & Safety Officer | 1.8yrs | no data | no data | |
| Chief Development & Property Officer | 3.6yrs | no data | no data |
1.4yrs
Average Tenure
Experienced Management: RYM's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.4yrs | NZ$221.67k | 0.0012% NZ$ 42.1k | |
| Advisor to the Board | 7.5yrs | NZ$2.73m | no data | |
| Independent Director | less than a year | NZ$53.87k | 0.0043% NZ$ 147.6k | |
| Independent Director | less than a year | no data | 0.0060% NZ$ 204.2k | |
| Non Executive Independent Director | 1.4yrs | NZ$109.17k | 0.0015% NZ$ 52.1k | |
| Independent Non-Executive Director | 10.2yrs | NZ$207.01k | 0.0058% NZ$ 198.0k | |
| Lead independent director | 5yrs | NZ$151.94k | 0.0046% NZ$ 158.6k | |
| Independent Director | 6.1yrs | NZ$161.91k | 0.0079% NZ$ 269.3k |
3.2yrs
Average Tenure
Experienced Board: RYM's board of directors are considered experienced (3.2 years average tenure).